Advanced Enzyme Technologies Ltd. Fundamental & Technical Research, Share Price Today

NSE : ADVENZYMES
NIFTY : NIFTY FULL SMALLCAP100

About Company

Advanced Enzymes Technologies Limited is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics. The company’s aim is to help consumers to access side-effect free healthcare, help farmers enhance nutrition for animals, and also to help the industry replace traditional thermal-chemical-mechanical processes into enzyme passed processes. Having pioneered the production of enzymes in India, the company continues to set trends with the research & development of new applications for the use of enzymes across various industries. The company is equipped with state-of-the-art manufacturing facilities and research & development centers across India, U.S. and Europe.

Market Cap. ₹3,158 Cr.

52 Week - High/Low ₹571/258

P/E Ratio 33.36

P/B Ratio 5.44

Enterprise Value ₹3,152 Cr.

ROE % 19.61

RSI Value 45.54

EMA 50 294.46

EMA 200 346.96

Net Profit 108 Cr.

Net Profit 3year growth 52.26 Cr.

Net Profit 3 year (back) 71 Cr.

Debt to Equity 0.0 %

EPS Growth TTM -15.41 %

Current Ratio 6.21 %

100 Day SMA 317 Rs.

200 Day SMA 381 Rs.

21 Day SMA 287 Rs.

50 Day SMA 285 Rs.

Book Value 52 Rs.

EV/EBITDA Ratio 25

QoQ EPS Growth 66 %

QoQ Operating Profit Growth 63 %

QoQ Sales Growth 30 %

Sales Latest Quarter 101 Cr.

YoY Sales Growth 11 %

Market Cap. ₹3,158 Cr.

52 Week - High/Low ₹571/258

P/E Ratio 23.76

P/B Ratio 2.38

Enterprise Value ₹3,058 Cr.

ROE % 10.72

RSI Value 45.54

EMA 50 294.46

EMA 200 346.96

Net Profit 133 Cr.

Net Profit 3year growth 0.94 Cr.

Net Profit 3 year (back) 146 Cr.

Debt to Equity 0.02 %

EPS Growth TTM -3.18 %

Current Ratio 7.61 %

100 Day SMA 317 Rs.

200 Day SMA 381 Rs.

21 Day SMA 287 Rs.

50 Day SMA 285 Rs.

Book Value 118 Rs.

EV/EBITDA Ratio 14

QoQ EPS Growth 15 %

QoQ Operating Profit Growth 30 %

QoQ Sales Growth 16 %

Sales Latest Quarter 169 Cr.

YoY Sales Growth 5 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages